Are bedside colonoscopies performed in intensive care unit really useful?


Journal

Journal of critical care
ISSN: 1557-8615
Titre abrégé: J Crit Care
Pays: United States
ID NLM: 8610642

Informations de publication

Date de publication:
06 2021
Historique:
received: 26 10 2020
revised: 01 02 2021
accepted: 03 02 2021
pubmed: 23 2 2021
medline: 1 10 2021
entrez: 22 2 2021
Statut: ppublish

Résumé

Effectiveness of bedside Colonoscopies in Intensive Care Unit (CICU) might be limited by the poor quality of colonic preparation, and their feasibility. We sought to describe the indications and the profitability of CICU. Retrospective, bicenter observational study (2004-2015) in unselected critically ill patients. We questioned the clinical profitability of CICU, according to its indications and preparation. One hundred and eleven CICU were performed in 84 patients (sex ratio 1.4, 49 M/35F; age 72.9 years [61.7-84.7]), for lower gastro-intestinal bleeding in 67 patients (LGIB, 60.3%) and for other causes in 44 (39.6%). The profitability was more frequent when CICU was performed for another reason than LGIB (75% vs 28.3%; p < 0.0001). Preparation was good in 47 procedures (42.3%) and allowed 33 complete CICU (29.7%). Fifty-six CICU (50.4%) were performed as a 2nd investigation after a contrast enhanced computed tomography. Three CICU were complicated by 3 hemodynamic and 2 respiratory failures, but none of them were fatal. CICU is clinically useful in half of cases, in the diagnostic and the therapeutic management of critically ill patients. Its profitability is close to scheduled colonoscopies and superior in non-lower gastro-intestinal bleeding indications.

Identifiants

pubmed: 33618283
pii: S0883-9441(21)00025-3
doi: 10.1016/j.jcrc.2021.02.001
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-61

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Henri Duboc (H)

Université de Paris, CRI Inserm UMRS 1149, IAME Inserm UMR 1137, PHERE UMRS 1152, F-75018 Paris, France; AP-HP, Hopital Louis Mourier, DMU ESPRIT, Department of Gastroenterology, F-92700 Colombes, France.

Tazime Issoufaly (T)

Université de Paris, CRI Inserm UMRS 1149, IAME Inserm UMR 1137, PHERE UMRS 1152, F-75018 Paris, France; APHP, Hôpital Louis Mourier, DMU ESPRIT, Intensive Care Unit, F-92700 Colombes, France.

Heithem Soliman (H)

AP-HP, Hopital Louis Mourier, DMU ESPRIT, Department of Gastroenterology, F-92700 Colombes, France.

Benjamin Sztrymf (B)

APHP, Hôpital Antoine Béclère, Intensive Care Unit, Université Paris-Saclay, Paris, France.

Dominique Prat (D)

APHP, Hôpital Antoine Béclère, Intensive Care Unit, Université Paris-Saclay, Paris, France.

Matthieu Le Meur (M)

APHP, Hôpital Louis Mourier, DMU ESPRIT, Intensive Care Unit, F-92700 Colombes, France.

Mohammed Laissi (M)

APHP, Hôpital Louis Mourier, DMU ESPRIT, Intensive Care Unit, F-92700 Colombes, France.

Guillaume Berquier (G)

APHP, Hôpital Louis Mourier, DMU ESPRIT, Intensive Care Unit, F-92700 Colombes, France.

Didier Dreyfuss (D)

Université de Paris, CRI Inserm UMRS 1149, IAME Inserm UMR 1137, PHERE UMRS 1152, F-75018 Paris, France; APHP, Hôpital Louis Mourier, DMU ESPRIT, Intensive Care Unit, F-92700 Colombes, France.

Benoit Coffin (B)

Université de Paris, CRI Inserm UMRS 1149, IAME Inserm UMR 1137, PHERE UMRS 1152, F-75018 Paris, France; AP-HP, Hopital Louis Mourier, DMU ESPRIT, Department of Gastroenterology, F-92700 Colombes, France.

Jean-Damien Ricard (JD)

Université de Paris, CRI Inserm UMRS 1149, IAME Inserm UMR 1137, PHERE UMRS 1152, F-75018 Paris, France; APHP, Hôpital Louis Mourier, DMU ESPRIT, Intensive Care Unit, F-92700 Colombes, France.

Jonathan Messika (J)

Université de Paris, CRI Inserm UMRS 1149, IAME Inserm UMR 1137, PHERE UMRS 1152, F-75018 Paris, France; APHP, Hôpital Bichat, Service de Pneumologie B et Transplantation Pulmonaire, F-75018 Paris, France. Electronic address: jonathan.messika@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH